McEnany Patrick J's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 22, 2022
- Accession no.
- 0001161697-22-000556
- Filed
- Nov 22, 2022
- Trade date
- Nov 18-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.77M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McEnany Patrick JCIK 0000929985 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +350,000 | $2.24 | +$784,000 | 4,252,606 | Direct | |
| Nov 18, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −350,000 | $15.62 | −$5,467,000 | 3,902,606 | Direct | |
| Nov 21, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +150,000 | $2.24 | +$336,000 | 4,052,606 | Direct | |
| Nov 21, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −150,000 | $15.33 | −$2,299,500 | 3,902,606 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | MOption exerciseDisposed | −350,000 | $0.00 | $0 | 3,015,834 | Direct | |
| Nov 21, 2022 | Common Stock | MOption exerciseDisposed | −150,000 | $0.00 | $0 | 2,865,834 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.